Cost effectiveness of atorvastatin (Lipitor) as single therapy and dual therapy with ezetimibe (Zetia)

被引：0
|
作者：
Bui, T [1 ]
Harrison, DL [1 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62666-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：268 / 268
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF ADDING EZETIMIBE TO ATORVASTATIN THERAPY IN PORTUGAL
    Laires, P.
    Tun-Ying, H.
    Ambegaonkar, B. M.
    Davies, G. M.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A371 - A371
  • [2] Cost-effectiveness of adding ezetimibe to atorvastatin vs switching to rosuvastatin therapy in Portugal
    Laires, Pedro A.
    Ejzykowicz, Flavia
    Hsu, Tun-Ying
    Ambegaonkar, Baishali
    Davies, Glenn
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (08) : 565 - 572
  • [3] Cost effectiveness of adding ezetimibe to atorvastatin therapy in patients not at cholesterol treatment goal in Canada
    Kohli, Michele
    Attard, Cheryl
    Lam, Annette
    Huse, Daniel
    Cook, John
    Bourgault, Chantal
    Alemao, Evo
    Yin, Donald
    Marentette, Michael
    [J]. PHARMACOECONOMICS, 2006, 24 (08) : 815 - 830
  • [4] Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada
    Michele Kohli
    Cheryl Attard
    Annette Lam
    Daniel Huse
    John Cook
    Chantal Bourgault
    Evo Alemao
    Donald Yin
    Michael Marentette
    [J]. PharmacoEconomics, 2006, 24 : 815 - 830
  • [5] COST EFFECTIVENESS OF ADDING EZETIMIBE TO ATORVASTATIN THERAPY IN PATIENTS NOT AT LDL CHOLESTEROL TREATMENT GOAL IN BRAZIL
    Araujo, G. T.
    Fonseca, M.
    Etto, H.
    Davies, G. M.
    Hsu, T. Y.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A372 - A372
  • [6] Efficacy and safety of ezetimibe plus atorvastatin therapy
    Foody, JoAnne M.
    Toth, Peter P.
    Tershakovec, Andrew M.
    Musliner, Thomas
    Tomassini, Joanne E.
    Lowe, Robert S.
    Neff, David R.
    Davis, Harry R.
    [J]. CLINICAL LIPIDOLOGY, 2014, 9 (04) : 441 - 470
  • [7] Cost-effectiveness of statin monotherapy and combination therapy with ezetimibe.
    Coleman, CI
    Gillespie, EL
    Gryskiewicz, KA
    White, M
    [J]. PHARMACOTHERAPY, 2005, 25 (03): : 470 - 470
  • [8] Myopathy associated with atorvastatin-ezetimibe combination therapy
    Weffald, Linda A.
    Flach, Lynn A.
    [J]. PHARMACOTHERAPY, 2007, 27 (02): : 309 - 311
  • [9] Projected benefits and cost effectiveness of switching to dual inhibition therapy (ezetimibe/simvastatin) in Germany for patients not at goal on statin monotherapy
    Krobot, K. J.
    Davies, G. M.
    Alemao, E.
    Yin, D. D.
    Cook, J. R.
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 : 367 - 367
  • [10] GENERIC ATORVASTATIN, THE BELGIAN STATIN MARKET AND THE COST-EFFECTIVENESS OF STATIN THERAPY
    Simoens, S.
    Sinnaeve, P.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A381 - A381
12345